C07D 498/08
Bridged systems
C07D498/08 (Bridged systems) appears on 827 US grants and 1,114 published applications in this corpus.
Search patents in C07D- Granted patents
- 827
- Published applications
- 1,114
- Assignees
- 498
- Inventors
- 3,765
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 7 | 0 |
| 1978 | 6 | 0 |
| 1979 | 14 | 0 |
| 1980 | 13 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 6 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 2 |
| 2004 | 0 | 11 |
| 2005 | 2 | 12 |
| 2006 | 2 | 7 |
| 2007 | 13 | 14 |
| 2008 | 6 | 16 |
| 2009 | 5 | 21 |
| 2010 | 8 | 20 |
| 2011 | 9 | 30 |
| 2012 | 20 | 30 |
| 2013 | 29 | 50 |
| 2014 | 48 | 65 |
| 2015 | 52 | 52 |
| 2016 | 48 | 69 |
| 2017 | 52 | 50 |
| 2018 | 47 | 50 |
| 2019 | 84 | 65 |
| 2020 | 43 | 69 |
| 2021 | 49 | 65 |
| 2022 | 43 | 62 |
| 2023 | 38 | 93 |
| 2024 | 44 | 104 |
| 2025 | 47 | 81 |
| 2026 | 33 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PIKfyve kinase inhibitors22 Sep 2026US 12,741,960 B2Acurastem Incorporated
- Quinoxaline derivatives and uses thereof22 Sep 2026US 12,741,976 B2Black Diamond Therapeutics, Inc.
- Macrocyclic glucagon-like peptide 1 receptor agonists15 Sep 2026US 12,735,433 B2Eli Lilly and Company
- N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides8 Sep 2026US 12,729,196 B2AstraZeneca AB
- Bicyclic compound and use thereof25 Aug 2026US 12,715,866 B2SK Biopharmaceuticals Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Inhibitor of complement factor b24 Sep 2026US 2026/0285845 A1Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
- Compounds and methods for degrading gspt124 Sep 2026US 2026/0285872 A1Pin Therapeutics, Inc.
- Pyrido[3,4-d]pyrimidinone and pyrimdllne aryl hydrocarbon receptor antagonists and uses thereof17 Sep 2026US 2026/0272944 A1
Most cited
By later US patents
- 4,5-Deoxymaytansinoids, their use and pharmaceutical compositions thereof298US 4,371,533 ATakeda Chemical Industries, Ltd. · 1983
- Fluorogenic and chromogenic three-dimensional ionophores as selective reagents for detecting ions in biological fluids128US 5,162,525 AAllied-Signal Inc. · 1992
- Aryl- or heteroaryl-substituted benzene compounds82US 8,410,088 B2Eisai R&D Management Co., Ltd. · 2013
- Regioselective synthesis of CCI-77975US 7,153,957 B2Wyeth · 2006
- Neprilysin inhibitors67US 8,586,536 B2Theravance, Inc. · 2013